cultivate(MD) - cultivate(MD)

Prana Surgical Completes First Clinical Procedures Using the Prana System™ in Early Feasibility Study

News / January 7, 2026

First-in-human procedures mark a critical milestone supporting the system’s clinical development Prana Surgical, a cultivate(MD) portfolio company, announced the completion of the first five clinical procedures using the Prana System™ as part of its early feasibility study in Australia. The Prana System™ has been developed to enable image-guided, minimally invasive surgery, conserving healthy tissue and […]

Prana Surgical Completes First Clinical Procedures Using the Prana System™ in Early Feasibility Study Read More »

Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty

News / December 3, 2025

Partnership will Expand Shoulder Innovations’ Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC Shoulder Innovations (NYSE: SI), a cultivate(MD) portfolio company, today announced a strategic partnership with Interventional Systems (INS), a developer of robotic solutions for minimally invasive surgery, to introduce a transformative shoulder-specific micro-robotic solution designed to further

Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty Read More »

HAPPE Spine Reaches 1,000 Patients

News / November 13, 2025

HAPPE Spine, a cultivate(MD) portfolio company with a proprietary biomaterial and manufacturing platform for creating bone-integrating implants, announces that the INTEGRATE®-C Interbody Fusion System has been implanted in more than 1,000 patients, demonstrating clinical adoption of the HAPPE® platform across more than 30 surgeon users and 40 facilities nationwide.

HAPPE Spine Reaches 1,000 Patients Read More »

Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance

News / November 12, 2025

Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the third quarter ended September 30, 2025. Third Quarter & Recent Business Highlights “We are very excited about our accelerating momentum through 2025, with first-half year-over-year revenue growth of 37% expanding to 58% in the third quarter,

Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance Read More »

Shoulder Innovations Announces Full Commercial Launch of the InSet™ 70 Humeral Stem

Press Release / September 22, 2025

Expansion of the I-Series Humeral Stem Product Line Further Strengthens Robust Shoulder Arthroplasty Portfolio Grand Rapids, MI – September 22, 2025 – Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company exclusively focused on transforming the shoulder surgical care market, today announced the full commercial launch of the InSet™ 70 Humeral Stem (“InSet™ 70”). The

Shoulder Innovations Announces Full Commercial Launch of the InSet™ 70 Humeral Stem Read More »

Shoulder Innovations Reports Second Quarter 2025 Financial Results

Press Release / September 9, 2025

GRAND RAPIDS, Mich., Sept. 9, 2025 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2025. Recent Business Highlights “We are pleased with both our second quarter performance, which was in-line

Shoulder Innovations Reports Second Quarter 2025 Financial Results Read More »

Author name: cultivate(MD)